What We Do
From the earliest days of Hanson Wade’s creation, we have sought to provide insights on the most cutting-edge and emerging facets of drug development. What began with a meet-up of academic scientists and biotech CEOs researching circulating tumor cells (CTCs) over 12 years ago, has become a conference portfolio of 200+ niche events, networks, and an industry-defining database service that supports over 25,000 biopharma customers each year.
Why We Do It
We believe that specific, deep and comprehensive information supports increased approval rates, cheaper R&D and faster development of effective drugs to the right patients. Our niche approach to the market ensures our products and services address your specific challenges, in your exact scientific language.
Who We Are
We believe our role in the drug development ecosystem is to empower and give confidence to the R&D investments and decisions being made today, that will deliver safer and more effective frontline therapies for tomorrow. All Waders are united to play this role and bring their own passion for research, science and business development.